stockrow10x Genomics
TXG Healthcare Medical Devices
10x Genomics' revenue for fiscal 2025 (year ended December 2025) was $642.8 million, up 5.25% from fiscal 2024.
- Revenue
- +1.12%
- EPS
- +31.8%
- Free cash flow
- −4.61%
Quarter to September 2026, against a year earlier
Follow TXG
Alert me
10x Genomics (TXG) Operating margin
10x Genomics's operating margin over the twelve months to 30 September 2026 was −11.7%, down 2.2 percentage points from fiscal 2025 (−9.49%). Over the past ten years it has ranged from −178.7% (fiscal 2020) to −9.49% (fiscal 2025) — the current reading is the highest in ten years. That is in line with the Medical Devices industry median of −15.1% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −9.49% | 22.36 |
| FY2024 | −31.9% | 11.03 |
| FY2023 | −42.9% | (10.36) |
| FY2022 | −32.5% | (21.87) |
| FY2021 | −10.7% | 168.09 |
| FY2020 | −178.7% | (166.31) |
| FY2019 | −12.4% | 63.27 |
| FY2018 | −75.7% | (49.85) |
| FY2017 | −25.9% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | −10.7% | 2.29 |
| Jun 2026 | −13.0% | (1.65) |
| Mar 2026 | −11.3% | 0.47 |
| Dec 2025 | −11.8% | 9.87 |
| 27 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| GMED Globus Medical, Inc. compare | 21.7% |
| PODD Insulet Corporation compare | 18.4% |
| HAE Haemonetics Corporation compare | 12.8% |
| PEN Penumbra, Inc. compare | 12.1% |
| SNN Smith & Nephew SNATS, Inc. compare | 0.00% |
| BRKR Bruker Corporation compare | −1.99% |
| BIO.B Bio-Rad Laboratories, Inc. compare | −2.39% |
| BIO Bio-Rad Laboratories, Inc. compare | −2.39% |
| TXG 10x Genomics | −14.3% |
| Medical Devices industry median | −15.1% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on TXG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement